
CrossBridge Health
Using data to improve patient outcomes and save money on healthcare costs.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
* | N/A | Acquisition | |
Total Funding | 000k |


Related Content
CrossBridge is a technology company that bridges the gap between healthcare payers and providers using EMR-integrated, cloud-based technology. The company focuses on managing chronic inflammatory diseases, which have an annual care cost of $127.8 billion, surpassing even cancer treatment costs. CrossBridge aims to advance the treatment of inflammatory and autoimmune diseases and facilitate the transition to value-based care. The company develops clinical pathways and maintains an independent evidence-based disease library to improve health outcomes, reduce drug costs, and enhance administrative efficiency.
CrossBridge serves healthcare payers, specialist physicians, and patients, primarily in the fields of rheumatology, dermatology, gastroenterology, and neurology. The company operates in the healthcare technology market and employs a business model that leverages partnerships with healthcare providers to deliver evidence-based care. Revenue is generated through the implementation of their technology solutions, which streamline workflows, enable timely reimbursements, and ensure timely diagnoses and treatments.
Key features of CrossBridge's offerings include electronic pre-authorization at the time of prescription, alignment of provider and payer priorities, and efficient workflow administration. These features collectively contribute to better patient outcomes, lower healthcare costs, and administrative efficiency.
Keywords: value-based care, chronic diseases, inflammatory diseases, healthcare technology, EMR integration, clinical pathways, evidence-based, cost efficiency, specialist physicians, administrative efficiency.